Agilent Technologies, Inc. (A)
173.07
-0.82
(-0.47%)
USD |
NYSE |
Oct 23, 16:00
172.52
-0.55
(-0.32%)
After-Hours: 20:00
Agilent Technologies Enterprise Value : 50.99B for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 50.99B |
| October 22, 2026 | 51.22B |
| October 21, 2026 | 52.31B |
| October 20, 2026 | 50.97B |
| October 19, 2026 | 50.10B |
| October 16, 2026 | 50.96B |
| October 15, 2026 | 51.69B |
| October 14, 2026 | 51.25B |
| October 13, 2026 | 50.58B |
| October 12, 2026 | 50.50B |
| October 09, 2026 | 50.28B |
| October 08, 2026 | 49.61B |
| October 07, 2026 | 49.87B |
| October 06, 2026 | 49.94B |
| October 05, 2026 | 50.49B |
| October 02, 2026 | 49.50B |
| October 01, 2026 | 49.19B |
| September 30, 2026 | 50.78B |
| September 29, 2026 | 51.54B |
| September 28, 2026 | 51.59B |
| September 25, 2026 | 50.91B |
| September 24, 2026 | 50.93B |
| September 23, 2026 | 48.81B |
| September 22, 2026 | 49.35B |
| September 21, 2026 | 47.85B |
| Date | Value |
|---|---|
| September 18, 2026 | 46.31B |
| September 17, 2026 | 46.27B |
| September 16, 2026 | 45.53B |
| September 15, 2026 | 44.56B |
| September 14, 2026 | 43.58B |
| September 11, 2026 | 43.62B |
| September 10, 2026 | 42.55B |
| September 09, 2026 | 43.01B |
| September 08, 2026 | 43.60B |
| September 04, 2026 | 44.73B |
| September 03, 2026 | 44.48B |
| September 02, 2026 | 44.88B |
| September 01, 2026 | 44.47B |
| August 31, 2026 | 45.49B |
| August 28, 2026 | 45.57B |
| August 27, 2026 | 46.65B |
| August 26, 2026 | 45.92B |
| August 25, 2026 | 45.83B |
| August 24, 2026 | 45.45B |
| August 21, 2026 | 47.02B |
| August 20, 2026 | 46.26B |
| August 19, 2026 | 46.01B |
| August 18, 2026 | 44.05B |
| August 17, 2026 | 44.05B |
| August 14, 2026 | 44.07B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Thermo Fisher Scientific, Inc. | 284.58B |
| Danaher Corp. | 184.25B |
| Illumina, Inc. | 42.04B |
| Bio-Rad Laboratories, Inc. | 9.642B |
| Revvity, Inc. | 20.03B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 362.00M |
| Revenue (Quarterly) | 1.878B |
| Total Expenses (Quarterly) | 1.516B |
| EPS Diluted (Quarterly) | 1.279 |
| Gross Profit Margin (Quarterly) | 55.48% |
| Profit Margin (Quarterly) | 19.28% |
| Earnings Yield | 2.93% |
| Operating Earnings Yield | 3.62% |
| Normalized Earnings Yield | 3.152 |